Jocelyn Harding CEB DipDH

Oralieve UK

Joss is a dental hygienist based in Stroud Gloucestershire and has been at
Confident dental and Implant clinic for 11 years. Joss has been in dentistry
since 1987 and qualified whilst serving in the royal navy. 

Her passion for helping the mouths of cancer patients on their journey started three years ago as she started investigating what products were available. 

With help from specialists Joss wrote her first article, from this two helpful leaflets for both healthcare professionals and patients were created by the charity Brushupuk and have been downloaded all over the world. She has now published further practical articles for the dental care of cancer patients and dry mouth. 

Joss have spoken at many events and conferences nationally since being
published for both patients and medical and dental professionals. 
Joss is thrilled to be invited to be an Ambassador for MCF and is looking forward to helping more patients and professionals with in this area of care.

dont miss

The importance of mouth care for cancer patients

Oral care may be the last thing on a cancer patient’s mind but chemo and radiotherapy treatments may have side effects, which can make it difficult to eat, talk and chew. This presentation will look at practical ways cancer patients can improve their oral hygiene

Jocelyn Harding CEB DipDH will be speaking in the following theatre:

Theatre 12 - Wednesday 13.15 - 13.45: The importance of mouth care for cancer patients

EVEN MORE SEMINARS

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • James Flanagan: Speaking at the Oncology Convention

    James Flanagan
    Imperial College London

    Epigenetic biomarkers for platinum response in ovarian cancer

  • Mr Richard Steyn: Speaking at the Oncology Convention

    Mr Richard Steyn
    UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

    Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development

  • Clare Hutton & Peter Colley: Speaking at the Oncology Convention

    Clare Hutton & Peter Colley
    Hull & East Yorkshire Hospitals NHS Trust

    The Implementation & Development of IMRT in Hull